SABA overreliance is a major cause of concern globally and in India when it comes to asthma management. Increased SABA overusage has been directly related to poor clinical outcomes, increased risk of exacerbation and mortality. Asthma diagnosis, management and prevention of exacerbations has been especially challenging in light of the pandemic. Therefore, as a part of Cipla’s continuing effort in disseminating  knowledge on asthma management and eliminating SABA overreliance in India, we invite you for an expert forum on the 'Pandemic adjusted methods to diagnose and manage asthma with a focus on preventing exacerbations'. The expert talks will focus on the pandemic adjusted methods to manage asthma which will be followed by a panel round of experts discussing the practical considerations for asthma management during the pandemic, and the effective ways to prevent asthma exacerbation practiced both globally and in India.